Although two papers have explored GPRC5A function in pancreatic cancer [10, 11], they did not provide evidence from in vivo experiments or show that blocking downstream molecules disrupted the effect of GPRC5A. The gene discussed is GPRC5A; the disease is pancreatic neoplasm.